Condition: Superficial Basal Cell Carcinoma · Nodular Basal Cell Carcinoma · Nonmelanoma Skin Cancers · Sponsor: AiViva BioPharma, Inc.
To evaluate safety and efficacy of AIV001 treatment on low-risk Nonmelanoma Skin Caner of the basal cell carcinoma subtype.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| California Dermatology & Clinical Research Institute | Encinitas, California, United States | — |
| Island Dermatology | Newport Beach, California, United States | — |
| Skin Surgery Medical Group | San Diego, California, United States | — |
| Austin Institute for Clinical Research | Pflugerville, Texas, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04470726